UK markets open in 1 hour 44 minutes
NIKKEI 225
39,094.22 +477.12 (+1.24%) HANG SENG
18,922.04 -273.56 (-1.43%) CRUDE OIL
77.09 -0.48 (-0.62%) GOLD FUTURES
2,374.70 -18.20 (-0.76%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,563.23 -225.30 (-0.41%)
Theravance Biopharma, Inc. (0TB.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 408.41M |
| Enterprise value | 360.46M |
| Trailing P/E | N/A |
| Forward P/E | 12.77 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.61 |
| Price/book (mrq) | 2.15 |
| Enterprise value/revenue | 6.36 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.36 |
| 52-week change 3 | -17.33% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 10.60 |
| 52-week low 3 | 7.60 |
| 50-day moving average 3 | 8.50 |
| 200-day moving average 3 | 8.85 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 48.63M |
| Implied shares outstanding 6 | 48.91M |
| Float 8 | 15.28M |
| % held by insiders 1 | 14.64% |
| % held by institutions 1 | 104.44% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -72.78% |
| Operating margin (ttm) | -77.27% |
Management effectiveness
| Return on assets (ttm) | -5.66% |
| Return on equity (ttm) | -15.56% |
Income statement
| Revenue (ttm) | 61.51M |
| Revenue per share (ttm) | 1.19 |
| Quarterly revenue growth (yoy) | 39.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -41.74M |
| Net income avi to common (ttm) | -44.77M |
| Diluted EPS (ttm) | -0.82 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 99.97M |
| Total cash per share (mrq) | 2.06 |
| Total debt (mrq) | 47.9M |
| Total debt/equity (mrq) | 23.38% |
| Current ratio (mrq) | 5.74 |
| Book value per share (mrq) | 4.22 |
Cash flow statement
| Operating cash flow (ttm) | -16.8M |
| Levered free cash flow (ttm) | -6.25M |
© 2024 Yahoo. All rights reserved.